Compare
Myomo, Inc. vs Sanara MedTech Inc. vs Lakeland Industries Inc vs Establishment Labs Holdings Inc.
| Latest fiscal year | Myomo, Inc. MYO | Sanara MedTech Inc. SMTI | Lakeland Industries Inc LAKE | Establishment Labs Holdings Inc. ESTA |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-01-31 | 2025-12-31 |
| Revenue | $40.93M | $103.12M | $192.65M | $211.08M |
| Revenue growth (YoY) | +25.7% | +19.0% | +15.2% | +27.1% |
| Gross margin | 65.7% | 92.7% | 32.9% | 69.3% |
| Operating margin | -35.2% | 7.1% | -8.1% | -18.5% |
| Net margin | -38.1% | -36.4% | -13.1% | -24.2% |
| Net income | -$15.57M | -$37.56M | -$25.31M | -$51.06M |
| EPS (Diluted) | -$0.37 | -$4.36 | -$2.63 | -$1.72 |
| Operating cash flow | -$14.51M | $6.79M | -$15.75M | -$50.89M |
| Free cash flow | -$16.25M | $2.16M | -$16.42M | -$56.94M |
| Cash & equivalents | $14.13M | $16.58M | n/a | $75.57M |
| Total assets | $38.64M | $72.94M | $209.93M | $357.17M |
| Total liabilities | $27.23M | $67.01M | $80.81M | $333.62M |
| Shareholders' equity | $11.40M | $5.94M | $129.13M | $23.55M |
| Return on year-end equity | -136.6% | -632.5% | -19.6% | -216.9% |
| Shares outstanding | 38.47M | 8.95M | 9.81M | 29.30M |
Revenue, most recent five fiscal years
| Fiscal year | Myomo, Inc. | Sanara MedTech Inc. | Lakeland Industries Inc | Establishment Labs Holdings Inc. |
|---|---|---|---|---|
| Latest | $40.93M Ended 2025-12-31 | $103.12M Ended 2025-12-31 | $192.65M Ended 2026-01-31 | $211.08M Ended 2025-12-31 |
| 1 year earlier | $32.55M Ended 2024-12-31 | $86.67M Ended 2024-12-31 | $167.21M Ended 2025-01-31 | $166.03M Ended 2024-12-31 |
| 2 years earlier | $19.24M Ended 2023-12-31 | $64.99M Ended 2023-12-31 | $124.69M Ended 2024-01-31 | $165.15M Ended 2023-12-31 |
| 3 years earlier | $15.56M Ended 2022-12-31 | $45.84M Ended 2022-12-31 | $112.85M Ended 2023-01-31 | $161.70M Ended 2022-12-31 |
| 4 years earlier | $13.86M Ended 2021-12-31 | $24.14M Ended 2021-12-31 | $118.39M Ended 2022-01-31 | $126.68M Ended 2021-12-31 |